HCA Healthcare Q1 EPS Hits $7.15 as Cash Flow Jumps 22% Despite Volume Headwinds
HCA Healthcare reported Q1 EPS of $7.15, beating consensus by $0.03 and marking a 10.9% year-over-year increase, while revenue rose 4.3% to $19.11 billion. Same-facility admissions climbed 0.9% as operating cash flow jumped 22% to over $2 billion, though respiratory admissions fell 42%.
1. Q1 Financial Highlights
HCA Healthcare delivered first-quarter earnings per share of $7.15, surpassing the $7.12 consensus and representing a 10.9% increase from $6.45 a year earlier. Revenue climbed 4.3% to $19.11 billion, slightly above the $19.09 billion estimate, reflecting sustained demand for inpatient and outpatient services.
2. Operational Cash Generation and Admissions
Operating cash flow rose 22% to just over $2 billion, driven by efficiency gains and stronger billing collections. Same-facility admissions increased 0.9%, while equivalent admissions grew 1.3%, underpinned by modest inpatient and outpatient service expansion.
3. Respiratory Volume Decline and Weather Impact
Respiratory-related admissions plunged 42% and emergency room visits fell 32% year-over-year due to an unusually mild season, compounded by a significant January winter storm in key markets. These adverse volume trends offset part of the upside from supplemental Medicaid program benefits.
4. Outlook, Valuation and Resiliency Plan
Management reaffirmed full-year revenue guidance of $76.5 billion to $80 billion and adjusted EBITDA range of $15.55 billion to $16.45 billion, backed by a $400 million cost-savings resiliency plan. The stock trades at a P/E ratio of 14.78 and a current ratio of 0.80, suggesting stable valuation metrics amid operational headwinds.